γ-Glutamyltransferase is a predictor of incident diabetes and hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) study

Clinical Chemistry

Volumn 49, Issue 8, 2003, Pages 1358-1366

  Lee, Duk Hee ^a,b   Jacobs Jr , David R ^b,d   Gross, Myron ^c   Kiefe, Catarina I ^e,g   Roseman, Jeffrey ^f   Lewis, Cora E ^e   Steffes, Michael ^c  

^a Kosin University   (South Korea)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e University of Alabama at Birmingham   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENZYME ASSAY; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PREDICTION; PREVALENCE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; DIABETES MELLITUS; ENZYME TESTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; INCIDENCE; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 0041866784     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.8.1358     Document Type: Article

References (32)

1. Nystrom E, Bengtsson C, Lindstedt G, Lapidus L, Lindquist O, Waldenstrom J. Serum γ-glutamyltransferase in a Swedish female population. Age-related reference intervals; morbidity and in cases with raised catalytic concentration. Acta Med Scand 1988;224:79-84.
2. Nilssen O, Forde OH, Brenn T. The Tromso Study. Distribution and population determinants of γ-glutamyltransferase. Am J Epidemiol 1990;132:318-26.
3. Nilssen O, Forde OH. Seven-year longitudinal population study of change in γ-glutamyltransferase: the Tromso Study. Am J Epidemiol 1994;139:787-92.
4. Wannamethee G, Ebrahim S, Shaper AG. γ-Glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995;142:699-708.
5. Brenner H, Rothenbacher D, Arndt V, Schuberth S, Fraisse E, Fliedner TM. Distribution, determinants, and prognostic value of γ-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany. Prev Med 1997;26:305-10.
6. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum γ-glutamyltransferase and risk of NIDDM. Diabetes Care 1998;21:732-7.
7. Miura K, Nakagawa H, Nakamura H, Tabata M, Nagase H, Yoshida M, et al. Serum γ-glutamyl transferase level in predicting hypertension among male drinkers. J Hum Hypertens 1994;8:445-9.
8. Jousilahti P, Rastenyte D, Tuomilehto J. Serum γ-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000;31:1851-5.
9. Lee DH, Ha MH, Kim JR, Gross M, Jacobs DR. γ-Glutamyltransferase, alcohol, and blood pressure: a four year follow-up study. Ann Epidemiol 2002;12:90-6.
10. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, et al. γ-Glutamyltransferase and diabetes - a 4 year follow-up study. Diabetologia 2003;46:359-64.
11. Teschke R, Brand A, Strohmeyer G. Induction of hepatic microsomal γ-glutamyltransferase activity following chronic alcohol consumption. Biochem Biophys Res Commun 1977;75:718-24.
12. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-16.
13. Jacobs DR Jr, Hahn LP, Haskell WL, Pirie P, Sidney S. Validity and reliability of a short physical activity history: CARDIA and the Minnesota Heart Health Program. J Cardiopulmonary Rehabil 1989;9:448-59.
14. Morrow JD, Roberts LJ. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 1999;300:3-12.
15. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-50.
16. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002;35:373-9.
17. Kugelman A, Choy HA, Liu R, Shi MM, Gozal E, Forman HJ. γ-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am J Respir Cell Mol Biol 1994;11:586-92.
18. Takahashi Y, Oakes SM, Williams MC, Takahashi S, Miura T, Joyce-Brady M. Nitrogen dioxide exposure activates γ-glutamyl transferase gene expression in rat lung. Toxicol Appl Pharmacol 1997;143:388-96.
19. Karp DR, Shimooku K, Lipsky PE. Expression of γ-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. J Biol Chem 2001;276:3798-804.
20. Stark AA. Oxidative metabolism of glutathione by γ-glutamyl transpeptidase and peroxisome proliferation: the relevance to hepatocarcinogenesis. A hypothesis. Mutagenesis 1991;6:241-5.
21. Stark AA, Russell JJ, Langenbach R, Pagano DA, Zeiger E, Huberman E. Localization of oxidative damage by a glutathione-γ-glutamyl transpeptidase system in preneoplastic lesions in sections of livers from carcinogen-treated rats. Carcinogenesis 1994;15:343-8.
22. Paolicchi A, Tongiani R, Tonarelli P, Comporti M, Pompella A. γ-Glutamyl transpeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells. Free Radic Biol Med 1997;22:853-60.
23. Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M. γ-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 1998;25:786-92.
24. Brown KE, Kinter MT, Oberley TD, Freeman ML, Frierson HF, Ridnour LA, et al. Enhanced γ-glutamyl transpeptidase expression and selective loss of CuZn superoxide dismutase in hepatic iron overload. Free Radic Biol Med 1998;24:545-55.
25. Lakka TA, Nyyssonen K, Salonen JT. Higher levels of conditioning leisure time physical activity are associated with reduced levels of stored iron in Finnish men. Am J Epidemiol 1994;140:148-60.
26. Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 2002;51:2348-54.
27. Haffner SM. Epidemiology of hypertension and insulin resistance syndrome. J Hypertension 1997;15:S25-30.
28. Orie NN, Zidek W, Tepel M. Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens 1999;12:1169-74.
29. Cleland SJ, Petrie JR, Small M, Elliott HL, Connell JM. Insulin action is associated with endothelial function in hypertension and type 2 diabetes. Hypertension 2000;35:507-11.
30. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001;104:342-5.
31. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 2000;140:98-104.
32. Gillum RF. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men - the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord 2001;25:639-45.